Suzhou Highfine Biotech Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 27.14% vs 48.25% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -6.03% vs 16.78% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "171.90",
          "val2": "135.20",
          "chgp": "27.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.60",
          "val2": "35.70",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.50",
          "val2": "1.30",
          "chgp": "246.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.70",
          "val2": "34.80",
          "chgp": "-6.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "178.10%",
          "val2": "212.40%",
          "chgp": "-3.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 33.00% vs 16.09% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -17.38% vs 35.45% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "599.70",
          "val2": "450.90",
          "chgp": "33.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "143.00",
          "val2": "113.60",
          "chgp": "25.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.20",
          "chgp": "350.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.20",
          "val2": "5.60",
          "chgp": "28.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "110.80",
          "val2": "134.10",
          "chgp": "-17.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.60%",
          "val2": "207.50%",
          "chgp": "-3.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

171.90

135.20

27.14%

Operating Profit (PBDIT) excl Other Income

30.60

35.70

-14.29%

Interest

0.20

0.00

Exceptional Items

4.50

1.30

246.15%

Consolidate Net Profit

32.70

34.80

-6.03%

Operating Profit Margin (Excl OI)

178.10%

212.40%

-3.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 27.14% vs 48.25% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -6.03% vs 16.78% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

599.70

450.90

33.00%

Operating Profit (PBDIT) excl Other Income

143.00

113.60

25.88%

Interest

0.90

0.20

350.00%

Exceptional Items

7.20

5.60

28.57%

Consolidate Net Profit

110.80

134.10

-17.38%

Operating Profit Margin (Excl OI)

174.60%

207.50%

-3.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 33.00% vs 16.09% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -17.38% vs 35.45% in Dec 2024

All Annual Results